Figure 2

Cumulative incidence of end stage kidney disease (ESKD) according to albuminuria stage (with death as a competing risk) in elderly (≥ 65 years) patients with diabetes (a). The cumulative incidence of ESKD increased gradually with higher levels of albuminuria (P < 0.001 for all, A1 vs A2, A1 vs A3, and A2 vs A3). All-cause mortality according to albuminuria stage in elderly (≥ 65 years) patients with diabetes (b). Patients with normo albuminuria showed better survival rates than those with microalbuminuria or macroalbuminuria (P < 0.001 for A1 vs A2, P < 0.001 for A1 vs A3, and P = 0.942 for A2 vs A3). A1: normoalbuminuria (ACR < 30 mg/gCr), A2: microalbuminuria (ACR 30–300 mg/gCr), A3: macroalbuminuria (ACR > 300 mg/gCr). ACR, albumin-to-creatinine ratio.